Replies to post #107421 on Biotech Values

[HattieTheWitch]

Lupin is no stranger to the American Generic landscape. They have numerious US marketed drugs.

Why wouldn't they have brought their enox drug to the U.S. themselves?

Thanks for that information.

WOW. You've made a very, very significant point.

It's all adding up - stone after stone is being taken out of TEVA's foundation of credibility.

[jq1234]

Why wouldn't they [Lupin] have brought their enox drug to the U.S. themselves?

Lupin licensed from ItalFarmaco to market it in Indian market only. ItalFarmaco had marketed/licensed in/to several other countries under different brand names. Maybe ItalFarmaco licensed US rights to someone else already :-)!?

Lupin announced that it signed an in-licensing agreement with ItalFarmaco, a leading Italian pharmaceutical company. Lupin will exclusively market their cardiovascular critical care product, enoxaparin sodium injection, in pre-filled syringes under the brand name Lupenox in the Indian market.